Please assess the completion status of the following clinical trial:

Trial Title: Study of Doxorubicin in Patients With Metastatic Breast Cancer/Advanced Ovarian Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Availability of volunteer for the entire study period and willingness to adhere to protocol requirements as evidenced by written informed consent.~2. Patients with metastatic breast cancer/advanced ovarian cancer having age within the range of between 18-55 years.~3. Subjects who had no evidence of underlying disease~4. Subjects who had signed written consent form~Exclusion Criteria:~1. Females who were pregnant, breastfeeding, or are likely to become pregnant~2. Subjects who had any medical condition (except metastatic breast cancer/advanced ovarian cancer) that could jeopardize their health or prejudice the results~3. Subjects deemed uncooperative or noncompliant~4. Smoking or consumption of any nicotine products

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- SPARC-08-038 (Type: EXPERIMENTAL): 2 mg/ml
- Ref-08-038 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).